Drop-Ship Kits Today – Our Current GI-MAP Turnaround Time: 7–10 Business Days

Neurological Genomics Assessment and Therapeutics - Looking Beyond APOE

Tuesday, October 27, 2020 - 2:00 pm to 3:00 pm

Location

Webinar

Neurological diseases are partly driven by a complex interplay of environmental and genetic factors. When assessing patients with a strong family history or diagnosed with neurological disease, their genomic data can help identify underlying causes and opportunities for therapeutics. This is where the DSL GenomicInsight® test with Opus23 Explorer can assist in improving outcomes with your patients.

During this webinar, practitioners will learn relevant Genes/SNPs involved in Alzheimer’s disease and other forms of dementia. We will also discuss potential nutrient, herbal and lifestyle therapeutic options that can be employed based on this data.


Robert Boyd, ND, CNS

Presented by Robert Boyd, ND, CNS®

Dr. Robert Boyd is a Naturopathic Physician and Certified Nutrition Specialist® professional specializing in thyroid disorders, autoimmune disease and men’s health. He has spent years studying the fields of nutrigenomics as well as the gut microbiome and tailors many of his treatment approaches around these fascinating fields.

Dr. Boyd graduated Summa Cum Laude from the University of Bridgeport College of Naturopathic Medicine and completed Residency at the Center of Excellence in Generative Medicine under the tutelage of Dr. Peter D'Adamo, the creator of Opus23®. He is a co-founder of Terrain Clinic LLC, which has locations in Alexandria, VA and Washington D.C. He also holds an Adjunct Professor position teaching Nutrition at Trinity Washington University.
 

 

Neurological Genomics Assessment and Therapeutics - Looking Beyond APOE